methylprednisolone has been researched along with Ph 1 Chromosome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Béné, MC; Berthaud, P; Bilhou-Nabera, C; Bologna, S; Buzyn, A; Caillères, S; Castaigne, S; Coso, D; Darre, S; Delabesse, E; Delain, M; Delannoy, A; Dombret, H; Dubruille, V; Fohrer, C; Garban, F; Isnard, F; Legrand, O; Lhéritier, V; Raby, P; Raffoux, E; Reman, O; Rigal-Huguet, F; Sonet, A; Thomas, X; Turlure, P | 1 |
1 other study(ies) available for methylprednisolone and Ph 1 Chromosome
| Article | Year |
|---|---|
Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Disease-Free Survival; Humans; Imatinib Mesylate; Methylprednisolone; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Stem Cell Transplantation; Treatment Outcome | 2006 |